Patents by Inventor Rebekka Kubisch-Dohmen

Rebekka Kubisch-Dohmen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CILIOPATHIES
    Publication number: 20220211807
    Abstract: The present disclosure provides a pharmaceutical composition comprising a polyribonucleotide for use in treating a ciliopathy in a subject suffering of a ciliopathy, wherein the polyribonucleotide encodes a functional version of a protein a defect of which is associated with said ciliopathy, and wherein administration of said pharmaceutical composition to the respiratory system of said subject is effected when the subject shows an inflammation of the respiratory system. Further, the present disclosure relates to a method for analyzing the effect of a polyribonucleotide on ciliogenesis, wherein said polyribonucleotide encodes a protein involved in and/or required for ciliogenesis.
    Type: Application
    Filed: February 13, 2020
    Publication date: July 7, 2022
    Inventors: Carsten Rudolph, Verena Kretzschmann, Rebekka Kubisch- Dohmen, Christian Dohmen, Johannes Geiger, Manish Aneja, Ludwig Weiss, Heymut Omran, Petra Pennekamp, Kai Wohlgemuth, Sandra Cindric, Niki Tomas Loges, Johanna Raidt, Adrian Ter Steege
  • Ornithine transcarbamylase coding polyribonucleotides and formulations thereof
    Patent number: 11104887
    Abstract: In certain aspects, the disclosure relates to compositions comprising modified Ornithine transcarbamylase (OTC) polyribonucleotides and methods of use.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: August 31, 2021
    Assignee: ethris GmbH
    Inventors: Carsten Rudolph, Rebekka Kubisch-Dohmen, Manish Kumar Aneja, Johannes Geiger, Marino Schuhmacher
  • Cas9 mRNAs
    Patent number: 10927383
    Abstract: In certain aspects, the disclosure relates to compositions comprising modified Cas9 polyribonucleotides and methods of use, as well as Cas9 polynucleotides and polyribonucleotides.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: February 23, 2021
    Assignee: ethris GmbH
    Inventors: Manish Kumar Aneja, Rebekka Kubisch-Dohmen, Christian Plank, Carsten Rudolph
  • CAS9 MRNAS
    Publication number: 20180163213
    Abstract: In certain aspects, the disclosure relates to compositions comprising modified Cas9 polyribonucleotides and methods of use, as well as Cas9 polynucleotides and polyribonucleotides.
    Type: Application
    Filed: June 30, 2017
    Publication date: June 14, 2018
    Inventors: Manish Kumar Aneja, Rebekka Kubisch-Dohmen, Christian Plank, Carsten Rudolph